A new imidazole sulfate (1) and three known compounds (2-4) were isolated from the sponge Dercitus (Halinastra) japonensis. The structure of compound 1 was elucidated by spectroscopic means. Compound 2 was confirmed to show anti-HIV activity, whereas compounds 1, 3 and 4 were inactive.
Human immunodeficiency virus (HIV) was discovered in the middle 1980s as a causative agent of acquired immune deficiency syndrome (AIDS). Current therapy, named HAART (Highly Active Anti-Retroviral Therapy), against the disease by administering "cocktails" of drugs prevents the patients from development of the sickness, but they have to keep taking the medication as HAART cannot eradicate the virus [1] . However, there exists a demand for newer drugs for a complete cure.
In our quest for new antiviral drug leads not only for HIV, but for several viruses, we screened a library of 800 extracts of coral reef organisms collected along the islands of Okinawa. Chromatographic study of an anti-HIV extract led to four molecules (1-4) being obtained. Although the antiviral activity was ascribed to compound 2, a new compound 1, separated together with 2, is the subject of this note.
As the MeOH soluble extract of the sponge Dercitus japonensis showed anti-HIV activity, a portion of it was separated by gel filtration and reversed phase HPLC resulting in the isolation of compound 1 with three known compounds: ancorinolate B (2) [2], 2-aminoadenosine (3) [3] , and 2'-de-N-methylaplysinopsin (4) [4] . Each known compound was identified by comparing its spectroscopic data with those published.
Compound 1 was obtained as a glassy material and its negative HR-ESIMS showed pseudomolecular ions as C 5 H 7 N 2 O 4 32 S ([M-Na] -, Δ -0.27 mmu) and C 5 H 7 N 2 O 4 34 S ([M-Na] -, Δ -1.06 mmu) indicating three degrees of unsaturation without the valence of a sulfur atom. The 1 H NMR data contained characteristic low-field signals at δ 7.41 (1H, brs) and 8.87 (1H, d, J = 1.1 Hz), while the 13 C NMR spectrum showed three sp 2 signals at  116.4 (CH), 131.0 (C), and 133.6 (CH) suggesting the presence of a heteroaromatic moiety. With the presence of two nitrogen atoms in the molecule, it is likely to have a monosubstituted imidazole or pyrazole ring. Another structural feature is two consecutive methylenes at δ 2.91 (t, J = 6.4 Hz) and 3.99 (t, J = 6.4 Hz) showing COSY cross peaks with each other and also 13 C NMR signals at δ 24.8 and 63.8. Judging from the chemical shifts, one of the methylenes is oxygenated. The remaining structural unit was assigned as a sulfate (1223, 1062 cm -1 ) attached to the oxygenated methylene. The sulfate was confirmed as a sodium salt by atomic absorption spectroscopy (AAS). Therefore, the structure of compound 1 was elucidated as an imidazole or a pyrazole with a sulfated ethanol moiety.
HMBC correlations between the aromatic portion and the ethyl group supported the two possible structures, however, it was not conclusive to determine either a pyrazole or imidazole derivative. Since aromatic proton and carbon signals of compound 1 showed close similarity to those ( 7.39 s, 8.91 d, J = 1.4 Hz;  116.1, 131.5, 133.2) of 2-(1H-imidazol-4-yl)-ethanol (5) and also to those ( 7.53 s, 9.04 d, J = 1.3 Hz;  116.7, 128.9, 133.7) of histamine dihydrochloride (6), an imidazole moiety was proved in 1. By treating compound 5 with sulfuric acid in the presence of dicyclohexylcarbodiimide (DCC) [5] , a trace amount of compound 1 was formed, giving a pseudomolecular ion (Δ -1.71 mmu). Thus, we concluded that compound 1 is sodium 2-(1H-imidazol-4-yl)ethyl sulfate. The anti-HIV activity of compounds 1-5 were evaluated as shown in Table 1 . Compound 2 showed moderate activity, but the other compounds did not show any activity.
Experimental
General: HPLC separation was carried out on either a Nacalai Cosmosil C18 (10×250 mm) or HILIC column (4.6×250 mm, 10×250 mm) with an HPLC unit composed of RI and UV detectors. NMR spectra were recorded on a Bruker AVANCE III spectrometer either in dimethylsulfoxide (DMSO)-d 6 or D 2 O. ESIMS data were recorded on a Jeol JMR-T-100LP mass spectrometer. FTIR and UV spectra were taken on Jasco FT/IR-6100 and Jasco V-660 spectophometers, while atomic absorption was recorded on a Hitachi Z-2010 instrument. All solvents used were reagent grade (Wako). Compounds 5 (Synthonix) and 6 (TCI) were purchased.
Sponge:
A specimen of the sponge Dercitus (Halinastra) japonensis van Soest, Beglinger & de Voogd (2010) was collected by hand with scuba at a reef of Yonaguni Island, Okinawa, September 1992. The specimen was brought back to the laboratory and kept frozen at -20ºC until extraction. The sponge was identified by NJdV and a voucher specimen coded RMNH POR 8684 is deposited at Naturalis Biodiversity Center.
Extraction and isolation:
The specimen (0.70 kg, wet weight) was soaked in acetone (1.0 L) 3 times at room temperature. The acetone solution was filtered and concentrated under vacuum, and the resulting material was partitioned between water and ethyl acetate (EtOAc). The water layer was concentrated and the residue washed with methanol (MeOH). The MeOH solution was concentrated to give a crude extract (49.8 g). As this extract showed inhibition against HIV, part of it (505.3 mg) was separated on a Sephadex LH-20 (Pharmacia) column (20 x 300 mm) using aqueous MeOH to give 8 fractions. The sixth fraction was found to contain compound 3 (16.7 mg). While waiting for anti-HIV assay results, we separated the last fraction to obtain compound 4 (11.6 mg) by C18 HPLC (0.01% TFA in CH 3 CN). As the fourth fraction showed anti-HIV activity, it was further separated by HILIC HPLC (CH 3 CN:H 2 O, 9:1) to give pure compound 2 (15.8 mg) and impure compound 1 (2.5 mg). To supply an additional amount of compound 1, another portion of the extract (303.3 mg) was successively separated by Sephadex LH-20 (aqueous MeOH), C18 HPLC (water), and HILIC HPLC (CH 3 CN:H 2 O, 9:1) to give pure compound 1 (3.6 mg).
Compound ( 
Anti-HIV assay:
For evaluation of anti-HIV activities, human Tcell line MT-4 cells were seeded in a 96-well plate at a density of 5 × 10 5 cells/mL in 100 μL/wells of Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10% fetal bovine serum and then cells were infected with HIV-1 strain IIIB at a viral multiplicity of infection of 0.001 in the presence of various concentrations of each compound. Moreover, to confirm the cytotoxic effects, MT-4 cells were inoculated with each compound at various concentrations without virus infection. After incubation at 37ºC in an atmosphere of 5% CO 2 for 5 days, cell viability was determined by WST-1 assay (Dojindo Molecular Technologies, Inc.) that measured absorbance at 450 and 650 nm using the sodium salt of 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3benzene disulfonate, which produces a highly water-soluble formazan dye. The calculation of the 50% virus inhibitory concentration (IC 50 ) and the 50% cytotoxic concentration (CC 50 ) of each compound were performed by statistical analysis software, GraphPad Prism (GraphPad Software, Inc.).
